Lonza Brings Small Scale Plant Online in China

BASEL, Switzerland — Lonza Group announced it brought its small scale plant on stream in September 2007, in Nansha Guangzhou, China; the company unveiled a significant investment plan in April 2006 to construct an integrated exclusive synthesis platform with R&D capabilities. The new facility, which operates under cGMP (current good manufacturing practice) conditions, is designed to accommodate a greater number of reactors including a dedicated and technologically advanced quality control (QC) lab capable of fulfilling the increasing requirements of regulatory authorities. In the completed first build-out phase, six smaller reactors including distillation and filtration units have been installed. The plant is designed for production of quantities from 10 kg up to several hundred kilograms.

In additional news, Lonza completed a significant upgrade of its enzyme production plant in Kourim, Czech Republic. The new facility will produce Altus Pharmaceuticals’ ALTU-135 commercial drug substance enzymes: lipase, protease and amylase.

For more information, visit www.Lonza.com or Booth #19013 at SupplySide West.

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines